Senestech (NASDAQ:SNES) Major Shareholder Purchases $114,188.76 in Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management purchased 181,252 shares of the company’s stock in a transaction dated Friday, October 16th. The stock was acquired at an average price of $0.63 per share, with a total value of $114,188.76. Following the completion of the transaction, the insider owned 1,686,546 shares of the company’s stock, valued at $1,062,523.98. This represents a 12.04% increase in their position. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Monday, October 19th, Glenbrook Capital Management purchased 376,552 shares of Senestech stock. The stock was bought at an average price of $0.70 per share, with a total value of $263,586.40.
• On Thursday, October 15th, Glenbrook Capital Management purchased 426,000 shares of Senestech stock. The shares were bought at an average cost of $0.77 per share, for a total transaction of $328,020.00.
• On Friday, August 7th, Glenbrook Capital Management acquired 6,490 shares of Senestech stock. The shares were bought at an average price of $1.30 per share, for a total transaction of $8,437.00.
• On Thursday, August 6th, Glenbrook Capital Management acquired 15,000 shares of Senestech stock. The shares were bought at an average price of $1.30 per share, for a total transaction of $19,500.00.

Senestech Price Performance

NASDAQ SNES traded up $0.05 during midday trading on Monday, hitting $0.70. The company had a trading volume of 1,245,150 shares, compared to its average volume of 375,681. The company has a market capitalization of $3.79 million, a PE ratio of -0.51 and a beta of 0.25. The company has a current ratio of 6.78, a quick ratio of 5.81 and a debt-to-equity ratio of 0.02. The firm has a 50-day moving average price of $0.93 and a 200-day moving average price of $1.34. Senestech, Inc. has a twelve month low of $0.55 and a twelve month high of $4.04.

Senestech (NASDAQ:SNES) last released its earnings results on Wednesday, August 5th. The company reported ($0.35) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.02. The firm had revenue of $0.77 million during the quarter, compared to the consensus estimate of $0.60 million. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%. As a group, analysts anticipate that Senestech, Inc. will post -1.28 earnings per share for the current fiscal year.

Institutional Trading of Senestech

An institutional investor recently bought a new position in Senestech stock. Diversify Wealth Management LLC acquired a new stake in Senestech, Inc. (NASDAQ:SNES) during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned about 0.36% of Senestech at the end of the most recent reporting period. Hedge funds and other institutional investors own 5.19% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings cut shares of Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, August 11th. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat, Senestech presently has an average rating of “Sell”.

About Senestech

SenesTech, Inc is a life sciences company focused on developing fertility-control technologies for managing pest populations. The company’s approach is designed to reduce the reproduction of rodents rather than relying solely on traditional lethal control methods.

SenesTech’s primary product is ContraPest, a liquid bait formulated to target the fertility of both male and female rats. The product is intended for use in settings such as commercial facilities, urban areas, agricultural operations and other locations where rodent populations can create health, safety or economic risks.